Key result
Higher comorbidity burden is linked to worse post-stroke cognitive function on MoCA and MMSE.
Cross-Sectional (n=97)
Answers are grounded in this paper and cite their sources.
Randomized trial examines cognitive function and comorbidities in stroke survivors, indicating comorbidity burden impacts cognition.
A considerable complication for stroke survivors is the subsequent development of cognitive decline or dementia. In this study, the relationship between the inflammation-centered comorbidity burden on post-stroke cognitive function among community-dwelling stroke survivors capable of independent living was examined. Data for this secondary analysis were collected from stroke survivors (n = 97) participating in a randomized clinical trial. Participants provided baseline responses, regarding cognitive function (mini-mental status exam, MMSE; Montreal cognitive assessment, MoCA), history of stroke comorbid conditions, and the Stroke Prognosis Instrument-II (SPI-II), an index of stroke comorbidity and recurrent stroke risk within the next two years. Relationships and differences between groups were tested for significance using Spearman’s correlation, Kruskal–Wallis, or Mann–Whitney U tests. Most stroke survivors (69%) had multiple comorbidities. Total SPI-II scores were negatively correlated to both MoCA and MMSE scores (r = −0.25, p = 0.01; r = −0.22, p = 0.03, respectively), and differences in MoCA scores among SPI-II risk groups (low, medium, high) were evident (p = 0.05). In contrast, there were no differences in MoCA or MMSE scores when comorbid conditions were examined individually. Lastly, no gender differences were evident in cognitive assessments. Our data support the premise that comorbidity’s burden impacts post-stroke cognitive decline, more than a single comorbid condition. Inflammation may be an important component of this comorbidity burden. Future studies that operationalize this concept will better illuminate the complex phenomenon of post-stroke cognitive decline for improved clinical rehabilitation modalities.
No takes yet. Share an insight, caveat, or question.
Morrison et al. (2022) conducted a cross-sectional in Stroke (n=97). Comorbidity burden (SPI-II score) vs. Single comorbid conditions / lower comorbidity burden was evaluated on Cognitive function (MoCA and MMSE scores) (r = -0.25 for MoCA; r = -0.22 for MMSE, p=0.01 for MoCA; 0.03 for MMSE). Higher comorbidity burden (total SPI-II scores) was negatively correlated with post-stroke cognitive function on both the MoCA and MMSE.
Synapse has enriched 10 related papers. Consider them for comparative context: